The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Antiretroviral Therapy and the Prevalence and Incidence of Diabetes Mellitus in the Multicenter AIDS Cohort Study
Open accessAbstract
BACKGROUND: The risk of diabetes mellitus (DM) in human immunodeficiency virus (HIV)-infected patients receiving highly active antiretroviral therapy (HAART) has not been well defined. METHODS: We conducted an analysis in the Multicenter AIDS Cohort Study to determine the prevalence and incidence of DM in this cohort of HIV-infected and HIV-seronegative men. Prevalence analysis included 1278 men (710 HIV seronegative and 568 HIV infected, 411 receiving HAART) with fasting glucose concentration determinations at baseline. Incidence analysis included 680 of these 1278 men who at the baseline visit had a fasting glucose concentration of 98 mg/dL (5.4 mmol/L) or less, no self-reported history of DM, and no self-reported use of antidiabetic medication. Diabetes mellitus was defined as a fasting glucose concentration of 126 mg/dL (7 mmol/L) or higher, self-reported diagnosis of DM, or self-reported use of antidiabetic medication. RESULTS: Fifty-seven (14%) of the 411 HIV-infected men using HAART at the baseline visit had prevalent DM compared with 33 (5%) of the 711 HIV-seronegative men (prevalence ratio = 4.6; 95% confidence interval, 3.0-7.1, adjusted for age and body mass index [calculated as weight in kilograms divided by the square of height in meters]). The rate of incident DM was 4.7 cases per 100 person-years among HIV-infected men using HAART compared with 1.4 cases per 100 person-years among HIV-seronegative men (rate ratio = 4.11; 95% confidence interval, 1.85-9.16, adjusted for age and body mass index), during the 4-year observation period, based on a median follow-up of 2.3 years. CONCLUSION: The incidence of DM in HIV-infected men with HAART exposure was greater than 4 times that of HIV-seronegative men, representing a risk that is higher than previous estimates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Modified Poisson Regression Approach to Prospective Studies with Binary Data
Zou, G. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh090 · Cited by 9,615
Harrell, F. E. (2001) · Springer Series in Statistics · doi:10.1007/978-1-4757-3462-1 · Cited by 9,195
Cox, D. R., & Oakes, D. (2018) · Chapman & Hall/CRC eBooks · doi:10.1201/9781315137438 · Cited by 6,234
Follow-up report on the diagnosis of diabetes mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2003) · Diabetes Care · doi:10.2337/diacare.26.11.3160 · Cited by 3,784
Carr, A., Samaras, K., Thorisdottir, A., Kaufmann, G. R., Chisholm, D. J., & Cooper, D. A. (1999) · The Lancet · doi:10.1016/s0140-6736(98)08468-2 · Cited by 1,495
KASLOW, R. A., OSTROW, D. G., DETELS, R., PHAIR, J. P., POLK, B. F., RINALDO, C. R., & STUDY, F. T. M. A. C. (1987) · American Journal of Epidemiology · doi:10.1093/aje/126.2.310 · Cited by 1,194
Hadigan, C., Meigs, J. B., Corcoran, C., Rietschel, P., Piecuch, S., Basgoz, N., Davis, B., Sax, P., Stanley, T., Wilson, P. W. F., et al. (2001) · Clinical Infectious Diseases · doi:10.1086/317541 · Cited by 680
Impact of HIV infection and HAART on serum lipids in men
Riddler, S. A. (2003) · JAMA · doi:10.1001/jama.289.22.2978 · Cited by 624
Self-citationThe Mechanism of Insulin Resistance Caused by HIV Protease Inhibitor Therapy
Murata, H., Hruz, P. W., & Mueckler, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000228200 · Cited by 586
Walli, R., Herfort, O., Michl, G. M., Demant, T., Jäger, H., Dieterle, C., Bogner, J. R., Landgraf, R., & Goebel, F. D. (1998) · AIDS · doi:10.1097/00002030-199815000-00001 · Cited by 519
Dybul, M., Fauci, A. S., Bartlett, J. G., Kaplan, J. E., & Pau, A. K. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-5_part_2-200209031-00001 · Cited by 482
Tsiodras, S., Mantzoros, C., Hammer, S., & Samore, M. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.13.2050 · Cited by 452
(2012) · Fluoropolymer Additives · doi:10.1016/b978-1-4377-3461-4.15001-9 · Cited by 442
Bondar, R. J. L., & Mead, D. C. (1974) · Clinical Chemistry · doi:10.1093/clinchem/20.5.586 · Cited by 357
Saves, M., Raffi, F., Capeau, J., Rozenbaum, W., Ragnaud, J., Perronne, C., Basdevant, A., Leport, C., Chene, G., & the Antiproteases Cohorte (APROCO) Study Group (2002) · Clinical Infectious Diseases · doi:10.1086/339866 · Cited by 254
Justman, J. E., Benning, L., Danoff, A., Minkoff, H., Levine, A., Greenblatt, R. M., Weber, K., Piessens, E., Robison, E., & Anastos, K. (2003) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200303010-00009 · Cited by 213
The metabolic effects of lopinavir/ritonavir in HIV-negative men
Lee, G. A., Seneviratne, T., Noor, M. A., Lo, J. C., Schwarz, J.-M., Aweeka, F. T., Mulligan, K., Schambelan, M., & Grunfeld, C. (2004) · AIDS · doi:10.1097/00002030-200403050-00008 · Cited by 206
Lichtenstein, K. A., Delaney, K. M., Armon, C., Ward, D. J., Moorman, A. C., Wood, K. C., & Holmberg, S. D. (2003) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200301010-00007 · Cited by 203
Wu, S., Li, C., & Ke, D. (2000) · Public Health · doi:10.1016/s0033-3506(00)00323-1 · Cited by 111
Ischemic Cardiovascular Disease in Persons with Human Immunodeficiency Virus Infection
David, M. H., Hornung, R., & Fichtenbaum, C. J. (2002) · Clinical Infectious Diseases · doi:10.1086/324745 · Cited by 99
The Effect of HAART and HCV Infection on the Development of Hyperglycemia Among HIV-Infected Persons
Mehta, S. H., Moore, R. D., Thomas, D. L., Chaisson, R. E., & Sulkowski, M. (2003) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200308150-00005 · Cited by 95
Martínez, E., Domingo, P., Galindo, M. J., Milinkovic, A., Arroyo, J. A., Baldoví, F., Larrousse, M., León, A., de Lazzari, E., & Gatell, J. M. (2004) · Clinical Infectious Diseases · doi:10.1086/382531 · Cited by 82
Mauss, S., Corzillius, M., Wolf, E., Schwenk, A., Adam, A., Jaeger, H., Knechten, H., Goelz, J., Goetzenich, A., & for the DAGNÄ Lipantiretroviral therapy study group (2002) · HIV Medicine · doi:10.1046/j.1464-2662.2001.00100.x · Cited by 62
Impaired Glucose Tolerance and Protease Inhibitors
Walli, R., Goebel, F. D., & Demant, T. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-10-199811150-00022 · Cited by 40
Direct interference of HIV protease inhibitors with pancreatic �-cell function
D�fer, M., Neye, Y., Krippeit‐Drews, P., & Drews, G. (2004) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-004-0933-6 · Cited by 30
Cited by
Triant, V. A., Lee, H., Hadigan, C., & Grinspoon, S. K. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2190 · Cited by 1,613
Gazzard, B., & on behalf of the BHIVA Treatment Guidelines Writing Group (2008) · HIV Medicine · doi:10.1111/j.1468-1293.2008.00636.x · Cited by 1,089
COVID-19 and diabetes mellitus: from pathophysiology to clinical management
Lim, S., Bae, J. H., Kwon, H.-S., & Nauck, M. A. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-00435-4 · Cited by 1,006
Diabetes in sub-Saharan Africa
Mbanya, J. C. N., Motala, A. A., Sobngwi, E., Assah, F. K., & Enoru, S. T. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60550-8 · Cited by 775
Feinstein, M. J., Hsue, P. Y., Benjamin, L. A., Bloomfield, G. S., Currier, J. S., Freiberg, M. S., Grinspoon, S. K., Levin, J., Longenecker, C. T., Post, W. S., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000695 · Cited by 658
Metadata
- Authors
- Brown, T. T.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2005-05-23
- Volume
- 165
- Issue
- 10
- Pages
- 1179
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2166168319
- Cited by
- 851
- References
- 25
- FWCI
- 34.46
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.